| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $16.0M | -27.3% | -33.6% |
| SG&A Expense | $10.4M | +0.5% | -8.2% |
| Operating Income | -$26.4M | +18.4% | +25.5% |
| Net Income | -$30.9M | -21.6% | +4.1% |
| EPS (Basic) | -$0.47 | -9.3% | +16.1% |
| EPS (Diluted) | -$0.47 | -9.3% | +16.1% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.4M | +25.8% | +57.5% |
| Short-term Investments | $33.7M | +25.5% | -72.3% |
| Accounts Receivable | $6.9M | +10.1% | +8.0% |
| Current Assets | $71.8M | +3.1% | -56.5% |
| Total Assets | $185.7M | -7.4% | -40.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$76.3M | — | — |
| Capital Expenditures | $65K | — | — |
| Investing Cash Flow | $53.0M | — | — |
| Financing Cash Flow | $22.3M | — | — |
| Free Cash Flow | -$76.3M | — | — |
| $80.8M |
| -5.6% |
| +45.2% |
| Long-term Debt | $154.9M | +0.0% | -6.1% |
| Stockholders' Equity | -$220.5M | +3.6% | -43.0% |